Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Factsheet on updated WHO guidelines for the screening, care and treatment of persons with hepatitis C infection from TREAT Asia/amfAR
Factsheet on updated WHO guidelines for the screening, care and treatment of persons with hepatitis C infection from TREAT Asia/amfAR
Download PDF
June 15, 2016
/
News
Share
the Post
Related
Posts
BMS’ patent bid for Hep C treatment Daclatasvir Challenged
Patient Groups and CSOs in Asia written a letter to Indian Government to Request Waiver on Local Clinical Trial for The Coming Generic DAAs
Pricing and availability of generic Indian daclatasvir as on 7 March 2016
Strategies to Secure Access to Generic HCV Medicines
20 YEARS AFTER THE TRIPS AGREEMENT, U.S. GOVERNMENT SCORES MASSIVE VICTORY FOR BIG PHARMA IN TPP DEAL
The Updated Pricing of Ledipasvir and Sofosbuvir Co-formulated tablets
Letter from Community in Asia and Eastern Europe to Global Fund Board for Financing Hep C Treatment
Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
